These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 11987015)

  • 21. Deterioration of insulin release rate response to glucose during oral glucose tolerance test is associated with an increased risk of incident diabetes in normal glucose tolerance subjects.
    Li Y; He S; Sun Y; Li G; Xu Q; Wang C; Jia W
    IUBMB Life; 2017 Sep; 69(9):756-766. PubMed ID: 28762247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A higher proinsulin response to glucose loading predicts deteriorating fasting plasma glucose and worsening to diabetes in subjects with impaired glucose tolerance.
    Inoue I; Takahashi K; Katayama S; Harada Y; Negishi K; Ishii J; Shibazaki S; Nagai M; Kawazu S
    Diabet Med; 1996 Apr; 13(4):330-6. PubMed ID: 9162608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?
    Wong MS; Gu K; Heng D; Chew SK; Chew LS; Tai ES
    Diabetes Care; 2003 Nov; 26(11):3024-30. PubMed ID: 14578234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: an interventional study.
    Wang Q; Jokelainen J; Auvinen J; Puukka K; Keinänen-Kiukaanniemi S; Järvelin MR; Kettunen J; Mäkinen VP; Ala-Korpela M
    BMC Med; 2019 Nov; 17(1):217. PubMed ID: 31779625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired glucose tolerance is not associated with lipid intolerance.
    Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
    Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.
    Henkel E; Gallo S; Siegert G; Koehler C; Hanefeld M
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):327-34. PubMed ID: 17473573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus.
    Meng LH; Huang Y; Zhou J; Liang XH; Xian J; Li L; Qin YF
    Chin Med J (Engl); 2017 Apr; 130(7):798-804. PubMed ID: 28345543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-stage atherosclerosis in newly diagnosed, untreated type 2 diabetes mellitus and impaired glucose tolerance.
    Gong W; Lu B; Yang Z; Ye W; Du Y; Wang M; Li Q; Zhang W; Pan Y; Feng X; Zhou W; Zhang Y; Yang Z; Yang Y; Zhu X; Hu R
    Diabetes Metab; 2009 Dec; 35(6):458-62. PubMed ID: 19879790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of genetic predisposition on proinsulin responses in Asian Indians.
    Ramachandran A; Snehalatha C; Satyavani K; Vijay V
    Diabetes Res Clin Pract; 1998 Jul; 41(1):71-7. PubMed ID: 9768375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES).
    Park SK; Ryoo JH; Oh CM; Choi JM; Choi YJ; Lee KO; Jung JY
    Diabetes Res Clin Pract; 2018 Dec; 146():130-137. PubMed ID: 28951335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
    Guerrero-Romero F; Rodríguez-Morán M
    Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Proportion of proinsulin two minutes after arginine stimulation: a pilot study].
    Wu SH; Ma XJ; Xiang KS; Lu JX; Lu W; Ding H
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2477-80. PubMed ID: 16321272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S; Abrahami M; Lilos P; Phillip M
    Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Model of development of diabetes mellitus in adult Chinese].
    Li G; Wang J; Chen C
    Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):914-7. PubMed ID: 11702665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
    Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
    Haffner SM; D'Agostino R; Festa A; Bergman RN; Mykkänen L; Karter A; Saad MF; Wagenknecht LE
    Diabetes Care; 2003 Oct; 26(10):2796-803. PubMed ID: 14514582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.